Likewise, the knockdown of PDIA3P and lnc-ANGPTL1-3 was associated with an increase of sensitivity to bortezomib treatment [60,85], while the upregulation of DARS-AS1 reduced the sensitivity of MM cells to this drug [41]. This evidence concerns the gene PDIA3P1 and Miyoshi myopathy.